|
⚲
|
| Keyboard |
| Wechsler Daniel Mark
✚
|
|
|---|---|
| CIK # | 0001582285 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001582285] | |
| 4 | [0001582285] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Melinta Therapeutics Inc /New/ | |
| Wechsler Daniel Mark | |
| Bausch Health Companies Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Melinta Therapeutics Inc /New/ MLNT
Stock Option (right to buy) · derivative
|
2018-06-12 | Grant | 150,000 | $0.00 | |
|
Melinta Therapeutics Inc /New/ MLNT
Common Stock
|
2018-05-29 | Buy | 50,000 | $5.00 | 250,000 |
|
Melinta Therapeutics Inc /New/ MLNT
Stock Option (Right to Buy) · derivative
|
2017-11-03 | Grant | 550,981 | $0.00 | |
|
Melinta Therapeutics Inc /New/ MLNT
Restricted Stock Units · derivative
|
2017-11-03 | Grant | 183,661 | $0.00 | |
|
Bausch Health Companies Inc VRX
Restricted Share Units · derivative
|
2013-08-12 | Grant | 31,600 | $0.00 | |
|
Bausch Health Companies Inc VRX
Non-Qualified Stock · derivative
|
2013-08-12 | Grant | 82,000 | $0.00 |